Promega ViaFect Transfection Reagent

Wednesday, 15 January, 2014 | Supplied by: Promega Pty Ltd


Promega has announced ViaFect Transfection Reagent, a tool for efficient DNA transfer into a wide variety of cell lines, including challenging suspension cells and stem-cell-derived lines. The product allows researchers to develop transfection-based assays in the cell line most relevant for their biology of interest.

Induced pluripotent stem cell (iPSC)-derived cell models, such as Cellular Dynamics International’s iCell Cardiomyocytes, show robust transfection with the reagent, enabling assays not possible with other reagents. The product is said to offer high-performance transfection in diverse cell lines and iPSC-derived tissue cells.

The low-toxicity reagent allows cells to stay healthy and metabolically active during transfection-based experiments, even at low cell densities, facilitating experiments where extended application of a treatment is needed. Cell viabilities of greater than 90% are said to be routinely observed following transfection with the product.

The reagent requires minimal optimisation with a simple three-step protocol. It does not require removal of serum, removal of culture medium or washing after introduction of the reagent/DNA complex. It contains no animal-derived components.

Online: www.promega.com
Phone: 03 9818 1466
Related Products

Microbiologics UV-BioTAG QC microorganisms for quality control testing

UV-BioTAG, a line of reference strains containing green fluorescent protein (GFP) markers, makes...

ProSci Incorporated ferroptosis antibodies

ProSci Incorporated's range of ferroptosis antibodies includes AIFM2, NCOA4, PEX3, PEX10,...

BioClean-D Coverall with Hood and Integrated Boots – Sterile S-BDFC

Sterile coveralls act as a barrier, preventing particles, dust, microbes and other contaminants...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd